Use of Systemic Biorregulatory Medicine in an Alopecic Canine Patient Associated with Metronomic Chemotherapy for the Management of Hepatoid Cell Carcinoma

DHT may inhibit hair growth by affecting mitochondrial function, leading to hair follicle miniaturization. Treatments like minoxidil and PP405 may promote hair growth by altering metabolic pathways, potentially counteracting DHT's effects.

A woman with androgenetic alopecia is using a treatment of topical finasteride with 7% minoxidil, spironolactone, and supplements like iron, vitamin D, biotin, and zinc. She is considering additional treatments like PRP and laser therapy but has not seen significant hair regrowth yet.

Rapamycin, finasteride, and minoxidil are discussed as a strategy for hair loss prevention and reversal. Pulsed dosing of rapamycin is suggested to avoid conflicting effects with minoxidil.

Hair loss treatments include finasteride, minoxidil, microneedling, dutasteride, CB-03-01, RU-58841, and experimental options like KY-19382 and stem cell therapy. Some treatments are considered ineffective or risky, such as ketoconazole, PRP, and low-level laser therapy.

The user is seeking a hair loss treatment that doesn't affect beard growth or pose risks to others, using topical finasteride and considering clascoterone and pyrilutamide. They are also using microneedling and ketoconazole shampoo, while avoiding oral finasteride, dutasteride, and minoxidil.

Orient Bio is developing a PLGA formulated version of Cyclosporine A to stimulate hair growth without its immunosuppressant effects. Users discuss various treatments like Clascoterone, PP405, minoxidil, and tacrolimus, expressing hope for new developments and sharing personal experiences with these treatments.